These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33084609)

  • 1. Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.
    Jaime-Pérez JC; Ramos-Dávila EM; Aguilar-Calderón P; Jiménez-Castillo RA; Gómez-Almaguer D
    Rev Invest Clin; 2020 Oct; 73(1):031-038. PubMed ID: 33084609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center.
    Jaime-Pérez JC; Aguilar-Calderón P; Jiménez-Castillo RA; Ramos-Dávila EM; Salazar-Cavazos L; Gómez-Almaguer D
    Ann Hematol; 2020 Nov; 99(11):2513-2520. PubMed ID: 32945941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
    Oved JH; Lee CSY; Bussel JB
    J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An escalating treatment strategy for children with severe chronic immune thrombocytopenia: Preliminary report from a single center.
    Fu L; Ma J; Gu H; Ma J; Wei Y; Chen Z; Wu R
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29006. PubMed ID: 33720524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
    Yildiz I; Ozdemir N; Celkan T; Soylu S; Karaman S; Canbolat A; Dogru O; Erginoz E; Apak H
    Pediatr Hematol Oncol; 2015; 32(6):406-14. PubMed ID: 26154620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
    Maroun MC; Ososki R; Andersen JC; Dhar JP
    Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.
    Bussel JB; Lee CS; Seery C; Imahiyerobo AA; Thompson MV; Catellier D; Turenne IG; Patel VL; Basciano PA; Elstrom RL; Ghanima W
    Haematologica; 2014 Jul; 99(7):1264-71. PubMed ID: 24747949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
    Patel VL; Mahévas M; Lee SY; Stasi R; Cunningham-Rundles S; Godeau B; Kanter J; Neufeld E; Taube T; Ramenghi U; Shenoy S; Ward MJ; Mihatov N; Patel VL; Bierling P; Lesser M; Cooper N; Bussel JB
    Blood; 2012 Jun; 119(25):5989-95. PubMed ID: 22566601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for children with immune thrombocytopenia: a systematic review.
    Liang Y; Zhang L; Gao J; Hu D; Ai Y
    PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
    Higashide Y; Hori T; Yoto Y; Kabutoya H; Honjo S; Sakai Y; Nojima M; Yoda M; Yamamoto M; Tsutsumi H
    Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of chronic idiopathic thrombocytopenic purpura in children.
    Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
    Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.